Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Monnet

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Cancer Research|August 15, 1994
Intrapleural production of interleukin 6 during mesothelioma and its modulation by gamma-interferon treatmentG Monti, M C Jaurand, I Monnet, et al.
Cancer|November 1, 1994
Intrapleural treatment with recombinant gamma-interferon in early stage malignant pleural mesotheliomaC Boutin, E Nussbaum, I Monnet, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques)M Riggi, P Ruffie, S Voisin, et al.
Statistics in Medicine|July 15, 1994
Triangular test and randomized trials: practical problems in a small cell lung cancer trialJ P Pignon, M Tarayre, A Auquier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase I/II study of escalating doses of vinorelbine in combination with oxaliplatin in patients with advanced non-small-cell lung cancerI Monnet, P Soulié, H de Cremoux, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). ATTIT. Association pour le Traitement des Tumeurs Intra ThoraciquesI Monnet, S Brienza, F Hugret, et al.
Muscle & Nerve|March 1, 1997
Muscle involvement in human immunodeficiency virus-infected patients is associated with marked selenium deficiencyP Chariot, M L Dubreuil-Lemaire, J Y Zhou, et al.
The Review of Scientific Instruments|February 4, 2012
Online in situ x-ray diffraction setup for structural modification studies during swift heavy ion irradiationC Grygiel, H Lebius, S Bouffard, et al.
The Annals of Thoracic Surgery|April 1, 1994
Extended operations after induction therapy for stage IIIb (T4) non-small cell lung cancerP Macchiarini, A R Chapelier, I Monnet, et al.
American Journal of Respiratory Cell and Molecular Biology|February 1, 1997
Differential responsiveness of human and rat mesothelioma cell lines to recombinant interferon-gammaL Phan-Bich, A Buard, J F Petit, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Cancer Research|August 15, 1994
Intrapleural production of interleukin 6 during mesothelioma and its modulation by gamma-interferon treatmentG Monti, M C Jaurand, I Monnet, et al.
Cancer|November 1, 1994
Intrapleural treatment with recombinant gamma-interferon in early stage malignant pleural mesotheliomaC Boutin, E Nussbaum, I Monnet, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques)M Riggi, P Ruffie, S Voisin, et al.
Statistics in Medicine|July 15, 1994
Triangular test and randomized trials: practical problems in a small cell lung cancer trialJ P Pignon, M Tarayre, A Auquier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase I/II study of escalating doses of vinorelbine in combination with oxaliplatin in patients with advanced non-small-cell lung cancerI Monnet, P Soulié, H de Cremoux, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). ATTIT. Association pour le Traitement des Tumeurs Intra ThoraciquesI Monnet, S Brienza, F Hugret, et al.
Muscle & Nerve|March 1, 1997
Muscle involvement in human immunodeficiency virus-infected patients is associated with marked selenium deficiencyP Chariot, M L Dubreuil-Lemaire, J Y Zhou, et al.
The Review of Scientific Instruments|February 4, 2012
Online in situ x-ray diffraction setup for structural modification studies during swift heavy ion irradiationC Grygiel, H Lebius, S Bouffard, et al.
The Annals of Thoracic Surgery|April 1, 1994
Extended operations after induction therapy for stage IIIb (T4) non-small cell lung cancerP Macchiarini, A R Chapelier, I Monnet, et al.
American Journal of Respiratory Cell and Molecular Biology|February 1, 1997
Differential responsiveness of human and rat mesothelioma cell lines to recombinant interferon-gammaL Phan-Bich, A Buard, J F Petit, et al.
Pageof 8